登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Patients’ characteristics after propensity score matching.
Patients’ characteristics after propensity score matching.
收藏
Figshare
2022-03-28 更新
2026-04-28 收录
临床疗效比较
因果推断研究
数据链接:
https://figshare.com/articles/dataset/Patients_characteristics_after_propensity_score_matching_/19436784
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Patients’ characteristics after propensity score matching.
应用场景:
创建时间:
2022-03-28
相关数据集
XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
结直肠癌化疗方案
临床疗效比较
Colorectal cancer will be resistant to Chemotherapy drugs after treated for a period of time .In the past, the classical treatment regiment was to change other drug after tumor progressed. In theory,
NIAID Data Ecosystem
8
0
Comparative Effectiveness of Manual Therapy, Exercise Therapy, and Combined Therapy for Chronic Low Back Pain: A Comprehensive Retrospective Cohort Study
慢性下背痛
临床疗效比较
Supplementary Materials (Supporting Information) · Table S1. Comparison of Included vs. Excluded Patients · Table S2. Missing Data Pattern by Outcome · Table S3. Baseline Characteris
Zenodo
2025-09-16 更新
7
0
Health outcomes per cohort for the overall AMPLE population after 2 years (ABA-1L vs. TNFi-1L).
临床疗效比较
生物医药研究
Health outcomes per cohort for the overall AMPLE population after 2 years (ABA-1L vs. TNFi-1L).
NIAID Data Ecosystem
3
0
Extracted outcomes of the enrolled studies for LA and OP in this meta-analysis.
元分析数据
临床疗效比较
Extracted outcomes of the enrolled studies for LA and OP in this meta-analysis.
Figshare
2020-09-28 更新
7
0
Baseline characteristics compared between the drug-free remission group and the non-remission group.
临床疗效比较
疾病缓解研究
Baseline characteristics compared between the drug-free remission group and the non-remission group.
NIAID Data Ecosystem
4
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广